LNA and alpha-L-LNA are promising candidates for the development of efficient oligonucleotide-based therapeutic agents. Here, we report dose-dependent inhibition of HIV-1 Tat-dependent trans activation by a 12-mer chimeric alpha-L-LNA/DNA oligomer. This oligomer exhibits a dose-dependency similar to that of the corresponding 12-mer chimeric LNA/2'-O-Me-RNA oligomer. In addition, we show that incorporation of alpha-L-LNA or LNA monomers into each of the two binding arms of a "10-23" DNAzyme markedly increases cleavage of the target RNA.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1081/NCN-120021963 | DOI Listing |
Publication Analysis
Top Keywords
lna alpha-l-lna
8
12-mer chimeric
8
alpha-l-lna therapeutic
4
therapeutic applications
4
applications lna
4
alpha-l-lna promising
4
promising candidates
4
candidates development
4
development efficient
4
efficient oligonucleotide-based
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!